American regulators rejected a type 1 diabetes treatment that analysts predicted would eventually eclipse $450 million in annual revenue.
The company reported poor operating performance in 2018, but has attempted to focus the attention of investors on its future.
Wind and solar power will continue to elbow their way onto the electric grid this year, but that's just the beginning.
A leading player in the solar energy industry and a fertilizer company with a twist are two affordable stocks worth a closer look.
This business has a cozy relationship with one of the country's largest ethanol producers, allowing it to pay a 12% distribution yield.
Brazil's oil major has clawed its way back to a $100 billion market cap. Should individual investors be as confident as Wall Street?
Investors with a long-term mind-set can look to these three stocks to inject growth into their portfolio.
The company notified the Securities and Exchange Commission that it couldn't file its annual report on time. It gave three reasons.
This year could prove pivotal to America's energy revolution. Enterprise Products Partners is ready.
A specialty petroleum products supplier, a propane distributor, and development-stage gold and copper miner have struggled mightily recently.
Things are looking up for the biodiesel producer, but is the stock a buy after more than doubling in the last year?
Sometimes in investing, bigger really is better. These three large-cap stocks could anchor your portfolio.
The sleepy laboratory hardware manufacturer has found itself on the radar of many investors lately.
The biopharma is wisely taking advantage of its lofty stock price to raise capital through a share offering.
The master limited partnerships of Antero Resources have merged, changed their name, switched to a new operating structure, and kept the same ticker.
The genetic testing leader announced full-year 2018 operating results, but the numbers were actually pretty poor.
The pharma company announced full-year 2018 operating results and reiterated the road map for the year ahead.
NextEra Energy Partners has a sweet relationship with the nation's largest renewable power generator -- and it pays a 4.4% dividend.
The agricultural sciences leader reported full-year 2018 operating results, then abruptly sank in early March.
The liquid biopsy pioneer has more than doubled since its IPO.